Lausanne, Switzerland

Ioannis Xenarios

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Université De Lausanne. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ioannis Xenarios. Retrieved from https://idiyas.com/inventor/ioannis-xenarios

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ioannis Xenarios: Innovator in Cancer Treatment

Introduction

Ioannis Xenarios is a prominent inventor based in Lausanne, Switzerland. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.

Latest Patents

Xenarios holds a patent for "Adoptive immunotherapy for treating cancer." This invention provides methods for producing and/or expanding tumor-infiltrating lymphocytes (TILs) that can be utilized in adoptive immunotherapy for cancer treatment. His work in this area is crucial for advancing cancer therapies and improving patient outcomes.

Career Highlights

Xenarios is affiliated with the Université de Lausanne, where he conducts his research. His dedication to the field of immunotherapy has positioned him as a key figure in the ongoing battle against cancer.

Collaborations

He collaborates with notable colleagues, including Marie-Agnes Doucey and Nicolas Guex, who contribute to his research efforts and enhance the impact of his work.

Conclusion

Ioannis Xenarios is a dedicated inventor whose work in cancer treatment through adoptive immunotherapy is paving the way for innovative therapeutic solutions. His contributions are vital to the advancement of medical science and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…